Douglas J. Rhee, MD

tyloxapol Enuclene Soln, 0.25% TID-QID PRN Cleaning/lubricating solution forartificial eyeswhite petrolatum/ Stye Ophthalmic Oint, 55%/32% PRN For external use only, not for ocular use.mineral oil/ Ointment Marketed to relieve some of thesteric acid symptoms associated with ahordeolum1 From Arch Ophthalmol 1990;108:689.2 Refer to Rhee DJ, Pyfer MF, eds. The Wills Eye Manual: Offi ce and Emergency Room Diagnosis and Treatment of Eye Disease, 3rd ed. (Philadelphia:Lippincott Williams & Wilkims, 1999) for protocol.3 From Ophthalmology 1998;105:1715–1720.I. DRUGS FOR HYPHEMADrug Trade Preparation Usual Dose Notesaminocaproic acid Amicar syrup, 250 mg/ml 50 mg/kg PO Q4 hr. For hyphema 1,2tabs, 500 mg (max dose = 30 gm/day) Orthostatic hypotension is asignificant side effectCarbopol 30% aminocaproic acid in Q6 hr Topical therapy for hyphema 32% carboxypolymethylenegeltranexamic acid 75 mg/kg/day in 3 divided Alternative therapy for traumaticdoses for 5 days hyphema 41 From Ophthalmology 1998;105:1715–1720.2 Not for pregnant women or patients with renal failure, coagulopathy.3 From Ophthalmology 1999;106:375–379.4 From Arch Ophthalmol 1997;115:1106–1112.Miscellaneous Conditions 103